BioNexus Gene Lab Corp.
BGLC
NASDAQ·Industrials·Industrial - Distribution·Mkt cap $3.7M
$1.55
▲ +3.33%
P/E
-1.23
Mkt Cap
$3.7M
52-Wk Range
$1.07–$6.10
52-Week Range
$1.07 - $6.10
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 72.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary liquid biopsy technology for early biomarker detection
- Established regional distribution network across Southeast Asia
- Dual revenue model combining stable chemical sales with high-growth diagnostics
- Strategic positioning in underserved Asian diagnostic markets
Bear Case
1 risk
- High volatility (beta 2.2). Larger-than-normal price swings expected.
Growth
No forward estimates available
Expanding adoption of non-invasive liquid biopsy testing in Southeast Asian healthcare systems
Value
Valuation data unavailable
Momentum
Falling
-33.2% over 3m
Quality
Thin
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying BGLC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 14, 2026
Most recent quarter reported revenue of $76.2K (-97% YoY). Reported EPS of -$0.12. Gross margin 17.1%.
Reported EPS · last 4Q
0 of 1 beats
Q3 26
—
Revenue trend · last 8Q
—
—
-10%
+14%
-3%
-81%
-99%
-97%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$2.6M
$2.5M
$2.1M
$2.3M
$2.5M
$483.8K
$22.8K
$76.2K
Margins · last 8Q
Gross
17.1%
Operating
—
Profit
-376.1%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How BGLC stacks vs Industrial - Distribution
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related